Tevogen TVGN
NASDAQ TVGN
$6.72 +0.10 (+1.51%)
As of: Oct 1, 2026 · 3:26 PM EDT

Tevogen (TVGN) Non Operating Income (2022 - 2023)

Updated

Tevogen (TVGN) posted Non Operating Income of -$181,416 for Q4 2023, compared with $2.83 million a year earlier.

Analysis

Tevogen (TVGN) Non Operating Income (2022 - 2023) Analysis & Trends

For FY2023, Tevogen's Non Operating Income came in at $2.21 million, down 58.8% from FY2022.

  • In prior years, Tevogen's Non Operating Income was $5.36 million in FY2022 and $152,675 in FY2021.
  • The Q4 2023 figure stands as the lowest quarterly Non Operating Income in data going back to Q1 2022.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $327,225 (Q3 2023), $331,524 (Q2 2023) and $1.73 million (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tevogen 27.60 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -181,416.00
Sep 30, 2023 327,225.00
Jun 30, 2023 331,524.00
Mar 31, 2023 1.73 Mn
Dec 31, 2022 2.83 Mn
Sep 30, 2022 1.81 Mn
Jun 30, 2022 465,583.00
Mar 31, 2022 256,891.00
API Access

Tevogen Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=TVGN&period=max&api_key=YOUR_API_KEY